These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9804073)

  • 1. Mouse paw edema induced by a novel bradykinin agonist and its inhibition by B2-antagonists.
    Ueno A; Naraba H; Oh-ishi S
    Jpn J Pharmacol; 1998 Sep; 78(1):109-11. PubMed ID: 9804073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FR190997, a novel bradykinin B2 agonist, expresses longer action than bradykinin in paw edema formation and hypotensive response.
    Ueno A; Naraba H; Kojima F; Morita E; Oh-ishi S
    Immunopharmacology; 1999 Dec; 45(1-3):89-93. PubMed ID: 10614995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo.
    Hayashi I; Ishihara K; Kumagai Y; Majima M
    Br J Pharmacol; 2001 Aug; 133(8):1296-306. PubMed ID: 11498515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
    Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
    Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
    Asano M; Hatori C; Sawai H; Johki S; Inamura N; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Mizutani T; Oku T; Nakahara K
    Br J Pharmacol; 1998 Jun; 124(3):441-6. PubMed ID: 9647466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors.
    Griesbacher T; Rainer I
    Immunopharmacology; 1999 Sep; 43(2-3):195-201. PubMed ID: 10596853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
    Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
    Campos MM; Henriques MG; Calixto JB
    Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor.
    Aramori I; Zenkoh J; Morikawa N; Asano M; Hatori C; Sawai H; Kayakiri H; Satoh S; Inoue T; Abe Y; Sawada Y; Mizutani T; Inamura N; Nakahara K; Kojo H; Oku T; Notsu Y
    Mol Pharmacol; 1997 Jul; 52(1):16-20. PubMed ID: 9224807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema.
    Campos MM; Calixto JB
    Br J Pharmacol; 1995 Mar; 114(5):1005-13. PubMed ID: 7780633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice.
    Corrêa CR; Kyle DJ; Chakraverty S; Calixto JB
    Br J Pharmacol; 1996 Feb; 117(3):552-558. PubMed ID: 8821548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
    Griesbacher T; Legat FJ
    Br J Pharmacol; 1997 Mar; 120(5):933-9. PubMed ID: 9138701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonists for kinin B1 and B2 receptors in the mouse.
    Nsa Allogho S; Gobeil F; Pheng LH; Nguyen-Le XK; Neugebauer W; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):558-62. PubMed ID: 9276128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral antinociception and oedema inhibition produced by NPC 18884, a non-peptidic bradykinin B2 receptor antagonist.
    de Campos RO; Alves RV; Ferreira J; Kyle DJ; Chakravarty S; Mavunkel BJ; Calixto JB
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):278-86. PubMed ID: 10543429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonpeptide mimic of bradykinin with long-acting properties.
    Aramori I; Zenkoh J; Morikawa N; Asano M; Hatori C; Sawai H; Kayakiri H; Satoh S; Inoue T; Abe Y; Sawada Y; Mizutani T; Inamura N; Iwami M; Nakahara K; Kojo H; Oku T; Notsu Y
    Immunopharmacology; 1999 Dec; 45(1-3):185-90. PubMed ID: 10615010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse.
    Corrêa CR; Calixto JB
    Br J Pharmacol; 1993 Sep; 110(1):193-8. PubMed ID: 8220879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
    Majima M; Kawashima N; Hiroshi I; Katori M
    Br J Pharmacol; 1997 Jun; 121(4):723-30. PubMed ID: 9208140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.
    Drube S; Liebmann C
    Br J Pharmacol; 2000 Dec; 131(8):1553-60. PubMed ID: 11139431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM; Calixto JB
    Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive effect of distinct bradykinin B2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats.
    Bandeira-Melo C; Calheiros AS; Silva PM; Cordeiro RS; Teixeira MM; Martins MA
    Br J Pharmacol; 1999 May; 127(2):315-20. PubMed ID: 10385228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.